Streetbeat News

Analyst Ratings

FLT

FleetCor Technologies reported better-than-expected Q2 financial results and issued FY23 revenue guidance above estimates. Morgan Stanley raised its price target from $243 to $244 on the stock.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:05 pm

LLY

Truist Securities analyst Robyn Karnauskas maintains a Buy rating on Eli Lilly (LLY) and raises the price target from $525 to $600.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 09, 2023 | 2:05 pm

UPS

Oppenheimer analyst Scott Schneeberger has maintained an 'Outperform' rating on United Parcel Service (UPS) and raised the price target from $188 to $195.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 2:03 pm

LLY

NVO

Eli Lilly's Q2 results exceeded expectations, leading to a spike in its share price and analysts raising their price targets. The company's Alzheimer's franchise and Mounjaro sales are seen as key growth pillars. Positive data from Novo Nordisk's obesity outcomes study is also expected to benefit Eli Lilly's SURMOUNT-MMO obesity outcomes study.

Portfolio Pulse from Priya Nigam

August 09, 2023 | 2:03 pm

DXCM

A significant investor has taken a bearish stance on DexCom (NASDAQ:DXCM), with 81% of recent trades being bearish. The price target for DexCom over the last 3 months has been between $95.0 and $130.0. The current price of DXCM is $113.49, up 2.99%. Analysts from Barclays, Canaccord Genuity, Citigroup, Piper Sandler, and Raymond James have maintained their ratings on DexCom, with price targets ranging from $138 to $160.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:02 pm

META

A significant investor has taken a bearish stance on Meta Platforms (NASDAQ:META), with 66% of recent trades being bearish and 33% bullish. The total amount for put options is $386,045 and for call options is $54,545. Whales have been targeting a price range from $200.0 to $380.0 for Meta Platforms over the last 3 months. Several financial institutions have maintained or upgraded their ratings on Meta Platforms, with price targets ranging from $335 to $389.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:02 pm

TTWO

Oppenheimer analyst Andrew Uerkwitz has reiterated an Outperform rating on Take-Two Interactive (NASDAQ:TTWO) and maintained a price target of $157.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 2:02 pm

QSR

Oppenheimer analyst Brian Bittner has reiterated an Outperform rating on Restaurant Brands Intl (NYSE:QSR) and maintained a price target of $83.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 2:01 pm

FLYW

Flywire (NASDAQ:FLYW) has received 9 analyst ratings in the last quarter, with 8 being bullish or somewhat bullish and 1 being indifferent. The average price target is $37.78, which is higher than the current price of $35.08, implying an upside. The average price target has increased by 9.51% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:01 pm

ALDX

Aldeyra Therapeutics (NASDAQ:ALDX) has received 5 analyst ratings in the last quarter, with 4 being bullish and 1 somewhat bullish. The average price target is $16.8, indicating an upside from the current price of $7.4899. However, this average has decreased by 40.0% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm